Serum transforming growth factor‐β1 levels increase in response to successful anti‐inflammatory therapy in ulcerative colitis

Abstract

Both transforming growth factor-beta1 and interferon-gamma may play a role in the injury-repair process in active ulcerative colitis. Variations in circulating transforming growth factor-beta1 levels in the first week of treatment seem to be related to the therapeutic response.